BE
BE · BE · BE-AMP-SAM131826-00
Suprefact Nasal 0.1 mg
ATC L02AE01
Last synced from FAMHP / AFMPS (Belgium) on
Identification
ManufacturerSanofi Belgium
CountryBE (BE)
ATC codeL02AE01
Dispensing—
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026
Packs · 3
- be_apb0432971
- be_apb0727990
- be_apb0895946
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Nasal spray, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Suprefact Nasal 0.1 mg",
"name_fr": "Suprefact Nasal 0.1 mg",
"name_nl": "Suprefact Nasal 0.1 mg",
"amp_code": "SAM131826-00",
"strengths": [
"0.1050",
"0.1050",
"0.1000",
"0.1000"
],
"pack_count": 2,
"substances": [
"Buserelin Acetate",
"Buserelin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Buserelin",
"authorisation_numbers": [
"BE131826"
]
}Related drugs
Other records sharing ATC code L02AE01.
- GBBuserelin 5.5mg/5.5ml solution for injection vialsNeon Healthcare Ltd
- GBBuserelin 5.5mg/5.5ml solution for injection vialsAlliance Healthcare (Distribution) Ltd
- FISuprecurSanofi Oy
- ISSuprecurSanofi-aventis Norge AS
- GBSuprecur 150micrograms/dose nasal sprayNeon Healthcare Ltd
- GBSuprecur 5.5mg/5.5ml solution for injection vialsNeon Healthcare Ltd
- FISuprecur Depotsanofi-Aventis Oy
- FISuprefactsanofi-Aventis Oy
Access this data programmatically
Query Suprefact Nasal 0.1 mg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.